Hirudoid (Chondroitin Polysulfate)

Hirudoid is applied to the skin for several therapeutic purposes related to inflammation and tissue repair. It is typically considered for the following clinical situations:

• Management of superficial bruising and contusions.
• Relief of minor swelling and edema associated with soft‑tissue injury.
• Support of healing in superficial hematomas.
• Adjunctive treatment of mild inflammatory skin conditions.
• Post‑procedural care to reduce localized swelling after minor dermatologic interventions.

• Chondroitin polysulfate, the active component of Hirudoid, is a sulfated glycosaminoglycan that mimics natural cartilage constituents. When applied topically, it is thought to interact with extracellular matrix proteins, enhancing water retention and providing a lubricating layer that facilitates tissue hydration. This environment may modulate inflammatory mediators and support the natural repair processes of the skin and underlying soft tissue, thereby reducing localized swelling and promoting healing.

Adverse reactions to Hirudoid are generally mild and limited to the site of application. They are categorized as follows:

Common

• Mild skin irritation or redness.
• Itching at the application site.
• Slight burning sensation.
• Dryness or peeling of the treated skin.

Serious

• Allergic contact dermatitis.
• Severe rash or hives.
• Ulceration or necrosis of the skin.
• Persistent swelling or pain unrelated to the original condition.

Before using Hirudoid, consider the following safety measures:

• Avoid application on broken, infected, or severely inflamed skin.
• Do not use on mucous membranes, eyes, or genital areas.
• Test a small area first if you have a history of skin sensitivity.
• Discontinue use and seek medical advice if signs of an allergic reaction appear.
• Keep the product out of reach of children and store at room temperature.
• Consult a healthcare professional before use during pregnancy or lactation, as safety data are limited.

Topical chondroitin polysulfate may interact with other skin products or systemic medications. Consider the following guidance:

Avoid

• Concurrent use with other topical corticosteroids or potent anti‑inflammatory creams without professional advice.
• Application over areas treated with chemical peels or laser therapy.

Use with caution

• Combining with systemic anticoagulants, as enhanced local bleeding risk is possible.
• Using alongside other topical agents that contain alcohol or strong irritants.
• Applying over large surface areas in patients with compromised skin barrier function.